628 related articles for article (PubMed ID: 9134967)
21. Effect of PT-treatment on ANP-mediated inhibition of adenylate cyclase and amylase release in rat parotid gland.
Shimomura H; Nashida T; Imai A
Mol Cell Biochem; 1994 Oct; 139(1):53-8. PubMed ID: 7531819
[TBL] [Abstract][Full Text] [Related]
22. Vip-induced cross-talk between G-proteins in membranes from rat anterior pituitary cells.
Cussac D; Kordon C; Enjalbert A; Saltarelli D
Cell Signal; 1993 Mar; 5(2):119-37. PubMed ID: 8499223
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures.
Patrizio M; Colucci M; Levi G
J Neurochem; 2001 Apr; 77(2):399-407. PubMed ID: 11299302
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies.
Sheriff S; Balasubramaniam A
J Biol Chem; 1992 Mar; 267(7):4680-5. PubMed ID: 1537851
[TBL] [Abstract][Full Text] [Related]
25. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
26. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.
Schoepp DD; Salhoff CR; Wright RA; Johnson BG; Burnett JP; Mayne NG; Belagaje R; Wu S; Monn JA
Neuropharmacology; 1996; 35(12):1661-72. PubMed ID: 9076745
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of NMDA receptor-mediated transmission in turtle cerebellar granule cells by activation of metabotropic glutamate receptors.
Kinney GA; Slater NT
J Neurophysiol; 1993 Feb; 69(2):585-94. PubMed ID: 7681476
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.
Akam EC; Carruthers AM; Nahorski SR; Challiss RA
Br J Pharmacol; 1997 Jul; 121(6):1203-9. PubMed ID: 9249258
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of inhibitory GTP binding regulatory protein in alpha 2-adrenoceptor-mediated inhibition of adenylate cyclase activity in cerebral cortical membranes of rats.
Kitamura Y; Nomura Y; Segawa T
J Neurochem; 1985 Nov; 45(5):1504-8. PubMed ID: 2995588
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E receptors in bovine adrenal medulla are coupled to adenylate cyclase via Gi and to phosphoinositide metabolism in a pertussis toxin-insensitive manner.
Negishi M; Ito S; Hayaishi O
J Biol Chem; 1989 Mar; 264(7):3916-23. PubMed ID: 2537296
[TBL] [Abstract][Full Text] [Related]
31. (1 S,3 R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in the neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide- and inhibitory cyclic AMP-coupled mGluRs.
Schoepp DD; Johnson BG; Monn JA
J Neurochem; 1996 May; 66(5):1981-5. PubMed ID: 8780026
[TBL] [Abstract][Full Text] [Related]
32. Effects of T-588, a novel cognitive enhancer, on ADP-ribosylation of G(s alpha) by cholera toxin and cyclic AMP accumulation in rat cerebral cortex.
Maekawa M; Miyazaki H; Ono S; Narita H; Murayama T; Nomura Y
Neurochem Int; 1999 Feb; 34(2):149-55. PubMed ID: 10213074
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships for a series of phenylglycine derivatives acting at metabotropic glutamate receptors (mGluRs).
Bedingfield JS; Kemp MC; Jane DE; Tse HW; Roberts PJ; Watkins JC
Br J Pharmacol; 1995 Dec; 116(8):3323-9. PubMed ID: 8719814
[TBL] [Abstract][Full Text] [Related]
34. Modulatory effects of NMDA on phosphoinositide responses evoked by the metabotropic glutamate receptor agonist 1S,3R-ACPD in neonatal rat cerebral cortex.
Challiss RA; Mistry R; Gray DW; Nahorski SR
Br J Pharmacol; 1994 May; 112(1):231-9. PubMed ID: 7913380
[TBL] [Abstract][Full Text] [Related]
35. The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells.
Chavis P; Shinozaki H; Bockaert J; Fagni L
J Neurosci; 1994 Nov; 14(11 Pt 2):7067-76. PubMed ID: 7965099
[TBL] [Abstract][Full Text] [Related]
36. Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine.
Winder DG; Conn PJ
J Neurosci; 1993 Jan; 13(1):38-44. PubMed ID: 8380851
[TBL] [Abstract][Full Text] [Related]
37. Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit.
Walseth TF; Zhang HJ; Olson LK; Schroeder WA; Robertson RP
J Biol Chem; 1989 Dec; 264(35):21106-11. PubMed ID: 2556393
[TBL] [Abstract][Full Text] [Related]
38. Metabotropic glutamate receptor agonists potentiate cyclic AMP formation induced by forskolin or beta-adrenergic receptor activation in cerebral cortical astrocytes in culture.
Balázs R; Miller S; Chun Y; O'Toole J; Cotman CW
J Neurochem; 1998 Jun; 70(6):2446-58. PubMed ID: 9603209
[TBL] [Abstract][Full Text] [Related]
39. Interaction between metabotropic receptors and purinergic transmission in rat hippocampal slices.
Casabona G; L'Episcopo MR; Di Iorio P; Ciccarelli R; De Bernardis E; Shinozaki H; Nicoletti F; Caciagli F
Brain Res; 1994 May; 645(1-2):13-8. PubMed ID: 8062075
[TBL] [Abstract][Full Text] [Related]
40. Design and models for estimating antagonist potency (pA2, Kd and IC50) following the detection of antagonism observed in the presence of intrinsic activity.
Ghosh K; Kowal D; Dawson LA; Tasse R
Neuropharmacology; 1999 Mar; 38(3):361-73. PubMed ID: 10219974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
